These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diminished reliability of tryptase as risk indicator of mastocytosis in older overweight subjects. Vos BJ, van der Veer E, van Voorst Vader PC, Mulder AB, van der Heide S, Arends S, Kluin-Nelemans JC, de Monchy JG, van Doormaal JJ, Oude Elberink JN. J Allergy Clin Immunol; 2015 Mar; 135(3):792-8. PubMed ID: 25129675 [Abstract] [Full Text] [Related]
3. Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM. Alvarez-Twose I, Zanotti R, González-de-Olano D, Bonadonna P, Vega A, Matito A, Sánchez-Muñoz L, Morgado JM, Perbellini O, García-Montero A, De Matteis G, Teodósio C, Rossini M, Jara-Acevedo M, Schena D, Mayado A, Zamò A, Mollejo M, Sánchez-López P, Cabañes N, Orfao A, Escribano L, Spanish Network on Mastocytosis (REMA), Italian Network on Mastocytosis (RIMA). J Allergy Clin Immunol; 2014 Feb; 133(2):520-8. PubMed ID: 23921094 [Abstract] [Full Text] [Related]
4. Biochemical markers predictive for bone marrow involvement in systemic mastocytosis. Donker ML, van Doormaal JJ, van Doormaal FF, Kluin PM, van der Veer E, de Monchy JG, Kema IP, Kluin-Nelemans HC. Haematologica; 2008 Jan; 93(1):120-3. PubMed ID: 18166795 [Abstract] [Full Text] [Related]
5. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes. Florian S, Krauth MT, Simonitsch-Klupp I, Sperr WR, Fritsche-Polanz R, Sonneck K, Födinger M, Agis H, Böhm A, Wimazal F, Horny HP, Valent P. Int Arch Allergy Immunol; 2005 Mar; 136(3):273-80. PubMed ID: 15722637 [Abstract] [Full Text] [Related]
7. Contribution of highly sensitive diagnostic methods to the diagnosis of systemic mastocytosis in the absence of skin lesions. Alvarez-Twose I, Matito A, Sánchez-Muñoz L, Morgado JM, Orfao A, Escribano L, van Doormaal JJ, van der Veer E, van Voorst Vader PC, Kluin PM, Mulder AB, van der Heide S, Arends S, Kluin-Nelemans JC, Oude Elberink JN, de Monchy JG. Allergy; 2012 Sep; 67(9):1190-1. PubMed ID: 22882359 [No Abstract] [Full Text] [Related]
8. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis. Proelss J, Wenzel J, Ko Y, Bieber T, Bauer R. J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486 [Abstract] [Full Text] [Related]
9. Cutaneous manifestations in Hymenoptera and Diptera anaphylaxis: relationship with basal serum tryptase. Potier A, Lavigne C, Chappard D, Verret JL, Chevailler A, Nicolie B, Drouet M. Clin Exp Allergy; 2009 May; 39(5):717-25. PubMed ID: 19302252 [Abstract] [Full Text] [Related]
10. Disease spectrum in patients with elevated serum tryptase levels. Aberer E, Savic S, Bretterklieber A, Reiter H, Berghold A, Aberer W. Australas J Dermatol; 2015 Feb; 56(1):7-13. PubMed ID: 24575854 [Abstract] [Full Text] [Related]
11. Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis. van Anrooij B, van der Veer E, de Monchy JG, van der Heide S, Kluin-Nelemans JC, van Voorst Vader PC, van Doormaal JJ, Oude Elberink JN. J Allergy Clin Immunol; 2013 Jul; 132(1):125-30. PubMed ID: 23498593 [Abstract] [Full Text] [Related]
12. Fatal Anaphylaxis to Yellow Jacket Stings in Mastocytosis: Options for Identification and Treatment of At-Risk Patients. Vos BJPR, van Anrooij B, van Doormaal JJ, Dubois AEJ, Oude Elberink JNG. J Allergy Clin Immunol Pract; 2017 Jul; 5(5):1264-1271. PubMed ID: 28499778 [Abstract] [Full Text] [Related]
13. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders. Divekar R, Butterfield J. Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439 [Abstract] [Full Text] [Related]
14. Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms. Alvarez-Twose I, González-de-Olano D, Sánchez-Muñoz L, Matito A, Jara-Acevedo M, Teodosio C, García-Montero A, Morgado JM, Orfao A, Escribano L. Int Arch Allergy Immunol; 2012 Oct; 157(3):275-80. PubMed ID: 22042301 [Abstract] [Full Text] [Related]
15. Long-term follow-up of indolent mastocytosis in adults. Kors JW, Van Doormaal JJ, Breukelman H, Van Voorst Vader PC, De Monchy JG. J Intern Med; 1996 Feb; 239(2):157-64. PubMed ID: 8568484 [Abstract] [Full Text] [Related]
16. Mastocytosis: state of the art. Horny HP, Sotlar K, Valent P. Pathobiology; 2007 Feb; 74(2):121-32. PubMed ID: 17587883 [Abstract] [Full Text] [Related]
17. High prevalence of fractures and osteoporosis in patients with indolent systemic mastocytosis. van der Veer E, van der Goot W, de Monchy JG, Kluin-Nelemans HC, van Doormaal JJ. Allergy; 2012 Mar; 67(3):431-8. PubMed ID: 22229787 [Abstract] [Full Text] [Related]
18. Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome. Sonneck K, Florian S, Müllauer L, Wimazal F, Födinger M, Sperr WR, Valent P. Int Arch Allergy Immunol; 2007 Mar; 142(2):158-64. PubMed ID: 17057414 [Abstract] [Full Text] [Related]
19. Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites. Keyzer JJ, de Monchy JG, van Doormaal JJ, van Voorst Vader PC. N Engl J Med; 1983 Dec 29; 309(26):1603-5. PubMed ID: 6646186 [Abstract] [Full Text] [Related]
20. Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis. Kristensen T, Broesby-Olsen S, Vestergaard H, Bindslev-Jensen C, Møller MB, Mastocytosis Centre Odense University Hospital. Eur J Haematol; 2013 Aug 29; 91(2):106-11. PubMed ID: 23621866 [Abstract] [Full Text] [Related] Page: [Next] [New Search]